Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Police raid French HQ...

    Police raid French HQ of pharma giant Merck

    Written by Ruby Khatun Khatun Published On 5 Oct 2017 4:19 AM  |  Updated On 18 Aug 2021 10:07 AM

    Paris: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical scandal, a source close to the probe said.


    More than 9,000 people in France have reported serious side effects from a new version of the drug Levothyrox, which Merck is planning to put on the market in other European countries.


    France in March became the first country where the new formula went on sale, but the government moved last month to restore the old version of Levothyrox, used by some three million people in France.


    The reported side effects of the new version included cramps, dizziness and hair loss.


    The raid was carried out by police from public health agency OCLAESP as part of a preliminary investigation into alleged misleading of customers, involuntary bodily harm and endangering lives.


    Merck confirmed that a search was carried out at its French headquarters in the eastern city of Lyon, saying it had been "expected" and that the company was cooperating with investigators. No arrests were made.


    Health authorities are investigating 62 legal complaints over the drug, which were filed with the high court charged with public health matters in France's second city of Marseille late last month.


    Limited quantities of the old version of the drug went back on sale in France yesterday.

    European countriesFrench HQheadquartersindian pharma newsLevothyroxmedical scandalMerckOCLAESPpharma giantpharma industry newspharma newspharma news indiapharmaceutical industry newsPolice raidpublic healthpublic health agencythyroid drug
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok